After market close on Friday, Forbes states Bristol drug good for "all types of cancer" - including the narrower application offered by DNDN. Like the early manufacture of cars, smaller less-well-capitalized players are often beaten by the big boys. http://blogs.forbes.com/sciencebiz/2010/06/bristols-big-win/?partner=yahootix Happy trading to all on Monday.